Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Proteomics01:33

Proteomics

7.3K
A proteome is the entire set of proteins that a cell type produces. We can study proteomes using the knowledge of genomes because genes code for mRNAs, and the mRNAs encode proteins. Although mRNA analysis is a step in the right direction, not all mRNAs are translated into proteins.
Proteomics is the study of proteomes' function. It involves the large-scale systematic study of the proteome to denote the protein complement expressed by a genome. Scientist Mark Wilkins coined the term...
7.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Surgical Outcomes of Nonmelanoma Skin Cancer Managed with Systematic Preoperative Reflectance Confocal Microscopy-Guided Margin Assessment: A Retrospective Cohort Study Comparing Wide Local Excision and Mohs Micrographic Surgery.

Diagnostics (Basel, Switzerland)·2026
Same author

Umbilical Melanoma: Where You Least Expect It.

The Australasian journal of dermatology·2026
Same author

EMA-Positive Superficial ALK-Rearranged Myxoid Spindle Cell Neoplasm (SAMS): A Case Report of a Rare Entity and Dermoscopic Findings.

Dermatology practical & conceptual·2026
Same author

Mucosal melanoma of the head and neck region: clinical-pathologic implications of tumor microenvironment evaluated with multiplex immunohistochemistry.

Virchows Archiv : an international journal of pathology·2026
Same author

Integrative genomic and immune landscape analysis of intimal sarcomas for emerging therapeutic targets and immunotherapy strategies.

Frontiers in immunology·2026
Same author

Prevalence and incidence of amyloid transthyretin amyloidosis in the USA: insights from claims databases and electronic health records.

Open heart·2025

Related Experiment Video

Updated: Jun 15, 2025

Novel Atomic Force Microscopy Based Biopanning for Isolation of Morphology Specific Reagents against TDP-43 Variants in Amyotrophic Lateral Sclerosis
13:31

Novel Atomic Force Microscopy Based Biopanning for Isolation of Morphology Specific Reagents against TDP-43 Variants in Amyotrophic Lateral Sclerosis

Published on: February 12, 2015

8.8K

A targeted proteomics approach to amyloidosis typing.

Matteo Conti1, Irene Poppi1, Thomas Matulli Cavedagna1

  • 1Clinical Mass Spectrometry, Metropolitan Laboratory AUSL, Bologna, Italy.

Clinical Mass Spectrometry (Del Mar, Calif.)
|August 28, 2024
PubMed
Summary

A new targeted proteomics method accurately identifies amyloidosis-causing proteins in tissues using mass spectrometry. This approach offers a sensitive and specific diagnostic tool for clinical research, aiding in personalized amyloidosis treatment.

Keywords:
AmyloidosisCardiac muscle tissueImmunoglobulin light chainsMass spectrometryProtein typingSubcutaneous adipose tissueTargeted proteomicsTransthyretin

More Related Videos

Biochemical Purification and Proteomic Characterization of Amyloid Fibril Cores from the Brain
09:00

Biochemical Purification and Proteomic Characterization of Amyloid Fibril Cores from the Brain

Published on: April 28, 2022

3.1K
Genetic Analysis of Hereditary Transthyretin Ala97Ser Related Amyloidosis
06:33

Genetic Analysis of Hereditary Transthyretin Ala97Ser Related Amyloidosis

Published on: June 9, 2018

7.7K

Related Experiment Videos

Last Updated: Jun 15, 2025

Novel Atomic Force Microscopy Based Biopanning for Isolation of Morphology Specific Reagents against TDP-43 Variants in Amyotrophic Lateral Sclerosis
13:31

Novel Atomic Force Microscopy Based Biopanning for Isolation of Morphology Specific Reagents against TDP-43 Variants in Amyotrophic Lateral Sclerosis

Published on: February 12, 2015

8.8K
Biochemical Purification and Proteomic Characterization of Amyloid Fibril Cores from the Brain
09:00

Biochemical Purification and Proteomic Characterization of Amyloid Fibril Cores from the Brain

Published on: April 28, 2022

3.1K
Genetic Analysis of Hereditary Transthyretin Ala97Ser Related Amyloidosis
06:33

Genetic Analysis of Hereditary Transthyretin Ala97Ser Related Amyloidosis

Published on: June 9, 2018

7.7K

Area of Science:

  • Proteomics
  • Mass Spectrometry
  • Clinical Diagnostics

Background:

  • Amyloidosis is a severe condition caused by protein deposits in organs and tissues.
  • Accurate protein identification is crucial for diagnosis and personalized treatment.
  • Current advanced methods like LC-MS/MS are limited to specialized centers.

Purpose of the Study:

  • To develop a targeted proteomics approach for amyloid protein typing.
  • To enable analysis using low-resolution mass spectrometry without laser microdissection.
  • To determine frequently encountered amyloid proteins (immunoglobulin light chains, transthyretin) and tissue-specific reference proteins.

Main Methods:

  • Tissue samples were digested, reduced, alkylated, and trypsinized to create peptide mixtures.
  • Peptides were purified by SPE and separated by LC.
  • Proteotypic peptides were detected using Multiple Reaction Monitoring (MRM) transitions.

Main Results:

  • The method demonstrated high specificity and sensitivity for detecting amyloid protein peptides.
  • Limit of detection (LOD) values were in the picomole range for key amyloid proteins in different tissues.
  • Ratios of amyloid to tissue-specific proteins correlated with amyloid deposit presence.

Conclusions:

  • This targeted proteomics approach provides sensitive and specific discrimination of amyloidosis-affected tissues.
  • The method is suitable for clinical research applications.
  • It facilitates the identification of amyloid proteins for better patient management.